A reappraisal of peripheral pain pathways

For 75 years, doctors classified pain nerves by how fast they send signals—a blunt tool that lumps together many different types of pain. Now, researchers are using genetics to identify individual nerve cells by their molecular signatures, then activating, silencing, or killing them in mice to see exactly which cells cause which pain sensations. This matters because chronic pain—back pain, nerve damage, arthritis—affects millions of people, yet current treatments often fail or cause addiction. The problem is that we have been treating all pain as if it were the same. This project aims to map the precise cellular wiring of pain pathways, from the skin to the spinal cord, using genetic tools and activity-dependent reporters that light up when a nerve fires. If successful, this work could identify specific cell types and molecular targets for entirely new classes of painkillers—drugs that block only the pain-causing nerves without numbing other sensations or producing a high. The researchers will also study human and primate genetics, increasing the chance that any targets they find will translate into real treatments. This is fundamental science with a clear clinical destination: a biological roadmap for designing safer, more effective pain therapies.